How transforming growth factor contributes to atrial fibrillation?
Publication/Presentation Date
2-1-2021
Abstract
Atrial fibrillation (AF) is the most common clinically significant arrhythmia. There are four fundamental pathophysiological mechanisms of AF including: electrical remodeling, structural remodeling, autonomic nervous system changes, and Ca2+ handling abnormalities. The transforming growth factor-β (TGF-β) superfamily are cytokines that have the ability to regulate numerous cell functions including proliferation, differentiation, apoptosis, epithelial-mesenchymal transition, and production of extracellular matrix. During the last decade numerous studies have demonstrated that TGF-β affects the architecture of the heart. TGF-β1 has been shown to be involved in the development and propagation of atrial fibrillation (AF). Investigators have studied TGF-β signaling in AF with the aim of discovering potential therapeutic agents. In this review we discuss the role of TGF-β in atrial fibrillation and specifically its role in atrial structural and electrical remodeling.
Volume
266
First Page
118823
Last Page
118823
ISSN
1879-0631
Published In/Presented At
Babapoor-Farrokhran, S., Tarighati Rasekhi, R., Gill, D., Alzubi, J., & Mainigi, S. K. (2021). How transforming growth factor contributes to atrial fibrillation?. Life sciences, 266, 118823. https://doi.org/10.1016/j.lfs.2020.118823
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
33309721
Department(s)
Administration and Leadership
Document Type
Article